-+ 0.00%
-+ 0.00%
-+ 0.00%

Canaccord Genuity Maintains Buy on Hinge Health, Lowers Price Target to $53

Benzinga·02/11/2026 20:05:50
Listen to the news
Canaccord Genuity analyst Richard Close maintains Hinge Health (NYSE:HNGE) with a Buy and lowers the price target from $65 to $53.